ACHE and early-onset autosomal dominant Alzheimer disease: Huperzine A was identified as an effective inhibitor of acetylcholinesterase [24], an enzyme responsible to hydrolyze neurotransmitter acetylcholine, and have thus been approved to treat Alzheimer’s disease in China.